This is a profile image of Richard Bartlett

Richard Bartlett


Helps medtech companies achieve rapid and sustained performance improvement and unlock new growth opportunities on the back of seismic shifts in healthcare, such as digital health and value-based healthcare

Richard is a partner in McKinsey’s London office where he leads McKinsey’s transformation work in medtech and support to investors in the sector in Europe. He brings broad experience, serving clients across the healthcare space including governments, health systems, providers, payers, investors, and medical-products companies in Western Europe and the Middle East. He is also a geographical leader in the United Kingdom for the McKinsey Health Institute, a not-for-profit entity within the firm that aspires to catalyze action to add a collective 45 billion years of higher-quality life for all people around the world.

His work focuses on commercial strategy and transformation in medical products and devices, and helping companies unlock value via digital health in medtech. He brings to his work a deep background in health-system strategy, as well as healthcare innovation.

Examples of Richard’s recent client work includes the following:

  • guiding end-to-end performance transformations with medical-device companies by focusing on commercial transformation—like growth and cost—but touching all parts of organization
  • designing the market-entry strategy for a remote monitoring and AI-enabled device company, which included the prioritization of markets, development of clear entry approach, and an end-to-end plan to enable scale-up across multiple markets
  • developing the commercial strategy and organizational structure for a mid-sized medical products company in Europe, the Middle East, and Africa
  • performing various due diligences, integrations, and post-merger support for different companies in the medical device and products space, including for strategics and private equity firms

Previously, and whilst on secondment from McKinsey, Richard was the cofounder and deputy director of “Innovations in Healthcare,” a not-for-profit agency established by McKinsey in partnership with the World Economic Forum and Duke University, which identifies leading-edge innovations and supports entrepreneurs as they scale up businesses and replicate them in different health systems.


Rethinking the in vitro diagnostic testing model in Europe,” McKinsey & Company, July 2023

Resilience in life sciences: Emerging stronger from the downturn,” McKinsey & Company, December 2022

How the medtech industry can capture value from digital health,” McKinsey & Company, May 2021

New models of healthcare,” McKinsey & Company, April 2017

Delivering affordable cancer care: A value challenge to health systems,” World Innovation Summit for Health, 2015

Transforming Healthcare through Human Capital,” Global Health Policy Summit, 2012


Innovations in Healthcare
Deputy director


University of Warwick
BS, industrial economics